Publikationen


  1. Verhasselt HL, Buer J, Dedy J, Ziegler R, Steinmann J, Herbstreit F, Brenner T, Rath PM: COVID-19 Co-infection with Legionell pneumophila in 2 Tertiary-Care Hospitals, Germany. Emerg Infect Dis 2021, 27(5):1535-1537.
  2. Totzeck A, Ramakrishnan E, Schlag M, Stolte B, Kizina K, Bolz S, Thimm A, Stettner M, Marchesi JR, Buer J, Kleinschnitz C, Verhasselt HL, Hagenacker T: Gut bacterial microbiota in patients with myasthenia gravis: results from the MYBIOM study. Ther Adv Neurol Diso 2021, 14.
  3. Stähr KD, A.; Buer, J.; Lang, S.: Meso- und Hypopharynx - Entzündungen. In: Referenz HNO-Heilkunde Edited by Guntinas-Lichius OK, J.P.; Lang, S. Stuttgart: Thieme; 2021: 659-669.
  4. Scharmann U, Kirchhoff L, Hain A, Buer J, Koldehoff M, Steinmann J, Rath PM: Evaluation of Three Commercial PCR Assays for the Detection of Azole-Resistant Aspergillus fumigatus from Respiratory Samples of Immunocompromised Patients. J Fungi (Basel) 2021, 7(2).
  5. Pastille E, Fassnacht T, Adamczyk A, Ngo Thi Phuong N, Buer J, Westendorf AM: Inhibition of TLR4 Signaling Impedes Tumor Growth in Colitis-Associated Colon Cancer. Front Immunol 2021, 12:669747.
  6. Palmieri V, Ebel JF, Ngo Thi Phuong N, Klopfleisch R, Vu VP, Adamczyk A, Zoller J, Riedel C, Buer J, Krebs P, Hansen W, Pastille E, Westendorf AM: Interleukin-33 signaling exacerbates experimental infectious colitis by enhancing gut permeability and inhibiting protective Th17 immunity. Mucosal Immunol 2021.
  7. Mahabadi AA, Mahmoud I, Dykun I, Totzeck M, Rath PM, Ruhparwar A, Buer J, Rassaf T: Diagnostic value of the modified Duke criteria in suspected infective endocarditis -The PRO-ENDOCARDITIS study. Int J Infect Dis 2021, 104:556-561.
  8. Knuschke T, Kollenda S, Wenzek C, Zelinskyy G, Steinbach P, Dittmer U, Buer J, Epple M, Westendorf AM: A Combination of Anti-PD-L1 Treatment and Therapeutic Vaccination Facilitates Improved Retroviral Clearance via Reactivation of Highly Exhausted T Cells. mBio 2021, 12(1).
  9. Hansen W, Luppus S, Barthel R, Chang DI, Broemstrup J, Zwarg T, Shibata J, Westendorf AM, Buer J, Scherbaum N: Heroin-assisted treatment of heroin-addicted patients normalizes regulatory T cells but does not restore CD4(+) T cell proliferation. Addict Biol 2021, 26(4):e12998.
  10. Dröge FS, K.; Daser, A.; Buer, J.; Dominas, N.: Mundhöhle - Infektionen. In: Referenz HNO-Heilkunde Edited by Guntinas-Lichius OK, J.P.; Lang, S. Stuttgart: Thieme; 2021: 757-783.
  11. Chapot V, Effenberg L, Dohmen-Ruetten J, Buer J, Kehrmann J: Evaluation of the Accelerate Pheno System for Rapid Identification and Antimicrobial Susceptibility Testing of Positive Blood Culture Bottles Inoculated with Primary Sterile Specimens from Patients with Suspected Severe Infections. J Clin Microbiol 2021, 59(5).
  12. Becker KA, Verhaegh R, Verhasselt HL, Keitsch S, Soddemann M, Wilker B, Wilson GC, Buer J, Ahmad SA, Edwards MJ, Gulbins E: Acid Ceramidase Rescues Cystic Fibrosis Mice from Pulmonary Infections. Infect Immun 2021, 89(2).
  13. Arweiler-Harbeck DB, J.; Saxe, J.: Äußeres Ohr - Infektionen und Entzündungen. In: Referenz HNO-Heilkunde Edited by Guntinas-Lichius OK, J.P.; Lang, S. Stuttgart: Thieme; 2021: 66-89.
  14. Adamczyk A, Pastille E, Kehrmann J, Vu VP, Geffers R, Wasmer MH, Kasper S, Schuler M, Lange CM, Muggli B, Rau TT, Klein D, Hansen W, Krebs P, Buer J, Westendorf AM: GPR15 facilitates recruitment of regulatory T cells to promote colorectal cancer. Cancer Res 2021. 
  15. Abberger H, Barthel R, Bahr J, Thiel J, Luppus S, Buer J, Westendorf AM, Hansen W: Neuropilin-1 Is Expressed on Highly Activated CD4(+) Effector T Cells and Dysfunctional CD4(+) Conventional T Cells from Naive Mice. J Immunol 2021, 207(5):1288-1297.
  16. Zoller J, Ebel JF, Khairnar V, Schmitt V, Klopfleisch R, Meiners J, Seiffart V, Hansen W, Buer J, Singer BB, Lang KS, Westendorf AM: CEACAM1 regulates CD8(+) T cell immunity and protects from severe pathology during Citrobacter rodentium induced colitis. Gut Microbes 2020:1-16.
  17. Westmeier D, Siemer S, Vallet C, Steinmann J, Docter D, Buer J, Knauer SK, Stauber RH: Boosting nanotoxicity to combat multidrug-resistant bacteria in pathophysiological environments. Nanoscale Adv 2020, 2(11):5428-5440.
  18. Scheffel F, Knuschke T, Otto L, Kollenda S, Sokolova V, Cosmovici C, Buer J, Timm J, Epple M, Westendorf AM: Effective Activation of Human Antigen-Presenting Cells and Cytotoxic CD8(+) T Cells by a Calcium Phosphate-Based Nanoparticle Vaccine Delivery System. Vaccines (Basel) 2020, 8(1).
  19. Scharmann U, Verhasselt HL, Kirchhoff L, Buer J, Rath PM, Steinmann J, Ziegler K: Evaluation of Two Lateral Flow Assays in BAL Fluids for the Detection of Invasive Pulmonary Aspergillosis: a Retrospective Two-Center Study. Mycoses 2020.
  20. Scharmann U, Kirchhoff L, Schmidt D, Buer J, Steinmann J, Rath PM: Evaluation of a Commercial Loop-mediated Isothermal Amplification (LAMP) Assay for Rapid Detection of Pneumocystis jirovecii. Mycoses 2020.
  21. Scharmann U, Kirchhoff L, Chapot VLS, Dziobaka J, Verhasselt HL, Stauf R, Buer J, Steinmann J, Rath PM: Comparison of four commercially available chromogenic media to identify Candida albicans and other medically relevant Candida species. Mycoses 2020.
  22. Pelzer BW, Seufert R, Koldehoff M, Liebregts T, Schmidt D, Buer J, Rath PM, Steinmann J: Performance of the AsperGenius(R) PCR assay for detecting azole resistant Aspergillus fumigatus in BAL fluids from allogeneic HSCT recipients: A prospective cohort study from Essen, West Germany. Med Mycol 2020, 58(2):268-271.
  23. Moelleken M, Jockenhofer F, Wiegand C, Buer J, Benson S, Dissemond J: Pilot study on the influence of cold atmospheric plasma on bacterial contamination and healing tendency of chronic wounds. J Dtsch Dermatol Ges 2020.
  24. Liedtke K, Alter C, Gunther A, Hovelmeyer N, Klopfleisch R, Naumann R, Wunderlich FT, Buer J, Westendorf AM, Hansen W: Endogenous CD83 Expression in CD4(+) Conventional T Cells Controls Inflammatory Immune Responses. J Immunol 2020.
  25. Lang S, Brandau S, Marchesi JR, Jablonska J, Thurnher D, Mattheis S, Buer J, Hussain T: [The microbiome in head and neck tumors-initial findings and outlook]. HNO 2020.
  26. Kirchhoff L, Weisner AK, Schrepffer M, Hain A, Scharmann U, Buer J, Rath PM, Steinmann J: Phenotypical Characteristics of the Black Yeast Exophiala dermatitidis Are Affected by Pseudomonas aeruginosa in an Artificial Sputum Medium Mimicking Cystic Fibrosis-Like Conditions. Front Microbiol 2020, 11:471.
  27. Kirchhoff L, Dittmer S, Weisner AK, Buer J, Rath PM, Steinmann J: Antibiofilm activity of antifungal drugs, including the novel drug olorofim, against Lomentospora prolificans. J Antimicrob Chemother 2020.
  28. Kirchhoff L, Dittmer S, Buer J, Rath PM, Steinmann J: In vitro activity of olorofim (F901318) against fungi of the genus, Scedosporium and Rasamsonia as well as against Lomentospora prolificans, Exophiala dermatitidis and azole-resistant Aspergillus fumigatus. Int J Antimicrob Agents 2020:106105.
  29. Kirchhoff L, Arweiler-Harbeck D, Arnolds J, Hussain T, Hansen S, Bertram R, Buer J, Lang S, Steinmann J, Hoing B: Imaging studies of bacterial biofilms on cochlear implants-Bioactive glass (BAG) inhibits mature biofilm. PLoS One 2020, 15(2):e0229198.
  30. Kehrmann J, Popp W, Delgermaa B, Otgonbayar D, Gantumur T, Buer J, Tsogbadrakh N: Two fatal cases of plague after consumption of raw marmot organs. Emerg Microbes Infect 2020:1-6.
  31. Kehrmann J, Effenberg L, Wilk C, Schoemer D, Ngo Thi Phuong N, Adamczyk A, Pastille E, Scholtysik R, Klein-Hitpass L, Klopfleisch R, Westendorf AM, Buer J: Depletion of Foxp3(+) regulatory T cells is accompanied by an increase in the relative abundance of Firmicutes in the murine gut microbiome. Immunology 2020, 159(3):344-353.
  32. Hansen W, Luppus S, Barthel R, Chang DI, Broemstrup J, Zwarg T, Shibata J, Westendorf AM, Buer J, Scherbaum N: Heroin-assisted treatment of heroin-addicted patients normalizes regulatory T cells but does not restore CD4(+) T cell proliferation. Addict Biol 2020:e12998.
  33. Domnich M, Riedesel J, Pylaeva E, Kurten CHL, Buer J, Lang S, Jablonska J: Oral Neutrophils: Underestimated Players in Oral Cancer. Front Immunol 2020, 11:565683.
  34. Choudhury AR, Ju ZY, Djojosubroto MW, Schienke A, Lechel A, Schaetzlein S, Jiang H, Stepczynska A, Wang CF, Buer J, Lee HW, von Zglinicki T, Ganser A, Schirmacher P, Nakauchi H, Rudolph KL: Cdkn1a deletion improves stem cell function and lifespan of mice with dysfunctional telomeres without accelerating cancer formation (vol 39, pg 99, 2007). Nature Genetics 2020, 52(5):548-548.
  35. Beck S, Sehl C, Voortmann S, Verhasselt HL, Edwards MJ, Buer J, Hasenberg M, Gulbins E, Becker KA: Sphingosine is able to prevent and eliminate Staphylococcus epidermidis biofilm formation on different orthopedic implant materials in vitro. J Mol Med (Berl) 2020, 98(2):209-219.
  36. Verhasselt HL, Radke J, Schmidt D, Killengray D, Scharmann U, Rickerts V, Hansen W, Seidel D, Falces-Romero I, Buer J, Rath PM, Steinmann J: Comparison of genotyping methods for Cunninghamella bertholletiae. Mycoses 2019.
  37. Thiel J, Alter C, Luppus S, Eckstein A, Tan S, Fuhrer D, Pastille E, Westendorf AM, Buer J, Hansen W: MicroRNA-183 and microRNA-96 are associated with autoimmune responses by regulating T cell activation. J Autoimmun 2019, 96:94-103.
  38. Sokolova V, Shi Z, Huang S, Du Y, Kopp M, Frede A, Knuschke T, Buer J, Yang D, Westendorf AM, Epple M: Session 5: Biomaterials - Inorganic. Biomed Tech (Berl) 2019, 64(s1):36-40.
  39. Ross B, Krull M, Rath P, Kribben A, Dopadlik D, Erlemann I, Wiegard-Szramek I, Tyczynski B, Buer J, Herbstreit F: Dialysis drains as a possible source for carbapenem-resistant pathogens causing an ICU outbreak. Infection 2019, 47(2):233-238.
  40. Pastille E, Wasmer MH, Adamczyk A, Vu VP, Mager LF, Phuong NNT, Palmieri V, Simillion C, Hansen W, Kasper S, Schuler M, Muggli B, McCoy KD, Buer J, Zlobec I, Westendorf AM, Krebs P: The IL-33/ST2 pathway shapes the regulatory T cell phenotype to promote intestinal cancer. Mucosal Immunol 2019.
  41. Ozmen D, Ozkan N, Guberina N, Fliessbach K, Suntharalingam S, Theysohn J, Buchter M, Forsting M, Buer J, Dudda M, Jager M, Wetter A: Computed-tomography-guided biopsy in suspected spondylodiscitis: Single-center experience including 201 biopsy procedures. Orthop Rev (Pavia) 2019, 11(1):7793. 
  42. Meiners J, Palmieri V, Klopfleisch R, Ebel JF, Japtok L, Schumacher F, Yusuf AM, Becker KA, Zoller J, Hose M, Kleuser B, Hermann DM, Kolesnick RN, Buer J, Hansen W, Westendorf AM: Intestinal Acid Sphingomyelinase Protects From Severe Pathogen-Driven Colitis. Front Immunol 2019, 10:1386.
  43. Krull M, Steinmann J, Heintschel von Heinegg E, Buer J, Sucharski A, Mattheis S, Lang S, Ross B: Microbiological contamination of ear, nose and throat (ENT) units. GMS Hyg Infect Control 2019, 14:Doc03.
  44. Kieffer D, Parohl N, Buer J, Ross B, Popp W: Betten- und Nacttisch-Aufbereitung im Krankenhaus nach Entlassung - eine Pilotstudie. HygMed 2019, 44(11):D114-D117.
  45. Kehrmann J, Menzel J, Saeedghalati M, Obeid R, Schulze C, Holzendorf V, Farahpour F, Reinsch N, Klein-Hitpass L, Streeck H, Hoffmann D, Buer J, Esser S, Group H-HS: Gut Microbiota in Human Immunodeficiency Virus-Infected Individuals Linked to Coronary Heart Disease. J Infect Dis 2019, 219(3):497-508.
  46. Hesse C, Kollenda S, Rotan O, Pastille E, Adamczyk A, Wenzek C, Hansen W, Epple M, Buer J, Westendorf AM, Knuschke T: A Tumor-Peptide-Based Nanoparticle Vaccine Elicits Efficient Tumor Growth Control in Antitumor Immunotherapy. Mol Cancer Ther 2019, 18(6):1069-1080.
  47. Bongard J, Schmitz AL, Wolf A, Zischinsky G, Pieren M, Schellhorn B, Bravo-Rodriguez K, Schillinger J, Koch U, Nussbaumer P, Klebl B, Steinmann J, Buer J, Sanchez-Garcia E, Ehrmann M, Kaiser M: Chemical validation of DegS as a target for the development of antibiotics with a novel mode of action. ChemMedChem 2019.
  48. Beck S, Sehl C, Voortmann S, Verhasselt HL, Edwards MJ, Buer J, Hasenberg M, Gulbins E, Becker KA: Sphingosine is able to prevent and eliminate Staphylococcus epidermidis biofilm formation on different orthopedic implant materials in vitro. J Mol Med 2019.
  49. Sokolova V, Loza K, Knuschke T, Heinen-Weiler J, Jastrow H, Hasenberg M, Buer J, Westendorf AM, Gunzer M, Epple M: A systematic electron microscopic study on the uptake of barium sulphate nano-, submicro-, microparticles by bone marrow-derived phagocytosing cells. Acta Biomater 2018, 80:352-363.
  50. Seufert R, Sedlacek L, Kahl B, Hogardt M, Hamprecht A, Haase G, Gunzer F, Haas A, Grauling-Halama S, MacKenzie CR, Essig A, Stehling F, Sutharsan S, Dittmer S, Killengray D, Schmidt D, Eskandarian N, Steinmann E, Buer J, Hagen F, Meis JF, Rath PM, Steinmann J: Prevalence and characterization of azole-resistant Aspergillus fumigatus in patients with cystic fibrosis: a prospective multicentre study in Germany. J Antimicrob Chemother 2018, 73(8):2047-2053.
  51. Robak OH, Heimesaat MM, Kruglov AA, Prepens S, Ninnemann J, Gutbier B, Reppe K, Hochrein H, Suter M, Kirschning CJ, Marathe V, Buer J, Hornef MW, Schnare M, Schneider P, Witzenrath M, Bereswill S, Steinhoff U, Suttorp N, Sander LE, Chaput C, Opitz B: Antibiotic treatment-induced secondary IgA deficiency enhances susceptibility to Pseudomonas aeruginosa pneumonia. J Clin Invest 2018, 128(8):3535-3545.
  52. Olsowski M, Hoffmann F, Hain A, Kirchhoff L, Theegarten D, Todt D, Steinmann E, Buer J, Rath PM, Steinmann J: Exophiala dermatitidis isolates from various sources: using alternative invertebrate host organisms (Caenorhabditis elegans and Galleria mellonella) to determine virulence. Sci Rep 2018, 8(1):12747.
  53. Knuschke T, Rotan O, Bayer W, Kollenda S, Dickow J, Sutter K, Hansen W, Dittmer U, Lang KS, Epple M, Buer J, Westendorf AM: Induction of Type I Interferons by Therapeutic Nanoparticle-Based Vaccination Is Indispensable to Reinforce Cytotoxic CD8(+) T Cell Responses During Chronic Retroviral Infection. Front Immunol 2018, 9:614.
  54. Kehrmann J, Chapot V, Buer J, Rating P, Bornfeld N, Steinmann J: Diagnostic performance of blood culture bottles for vitreous culture compared to conventional microbiological cultures in patients with suspected endophthalmitis. Eur J Clin Microbiol Infect Dis 2018, 37(5):889-895.
  55. Hoing B, Kirchhoff L, Arnolds J, Hussain T, Buer J, Lang S, Arweiler-Harbeck D, Steinmann J: Bioactive Glass Granules Inhibit Mature Bacterial Biofilms on the Surfaces of Cochlear Implants. Otol Neurotol 2018, 39(10):e985-e991.
  56. Westendorf AM, Skibbe K, Adamczyk A, Buer J, Geffers R, Hansen W, Pastille E, Jendrossek V: Hypoxia Enhances Immunosuppression by Inhibiting CD4+ Effector T Cell Function and Promoting Treg Activity. Cell Physiol Biochem 2017, 41(4):1271-1284.
  57. Ueffing K, Abberger H, Westendorf AM, Matuschewski K, Buer J, Hansen W: Conventional CD11c(high) Dendritic Cells Are Important for T Cell Priming during the Initial Phase of Plasmodium yoelii Infection, but Are Dispensable at Later Time Points. Front Immunol 2017, 8:1333.
  58. Sokolova V, Shi Z, Huang S, Du Y, Kopp M, Frede A, Knuschke T, Buer J, Yang D, Wu J, Westendorf AM, Epple M: Delivery of the TLR ligand poly(I:C) to liver cells in vitro and in vivo by calcium phosphate nanoparticles leads to a pronounced immunostimulation. Acta Biomater 2017, 64:401-410.
  59. Pastille E, Frede A, McSorley HJ, Grab J, Adamczyk A, Kollenda S, Hansen W, Epple M, Buer J, Maizels RM, Klopfleisch R, Westendorf AM: Intestinal helminth infection drives carcinogenesis in colitis-associated colon cancer. PLoS Pathog 2017, 13(9):e1006649.
  60. Parohl N, Stiefenhofer D, Heiligtag S, Reuter H, Dopadlik D, Mosel F, Gerken G, Dechene A, Heintschel von Heinegg E, Jochum C, Buer J, Popp W: Monitoring of endoscope reprocessing with an adenosine triphosphate (ATP) bioluminescence method. GMS Hyg Infect Control 2017, 12:Doc04.
  61. Ma Z, Liu J, Wu W, Zhang E, Zhang X, Li Q, Zelinskyy G, Buer J, Dittmer U, Kirschning CJ, Lu M: The IL-1R/TLR signaling pathway is essential for efficient CD8(+) T-cell responses against hepatitis B virus in the hydrodynamic injection mouse model. Cell Mol Immunol 2017, 14(12):997-1008.
  62. Loevenich K, Ueffing K, Abel S, Hose M, Matuschewski K, Westendorf AM, Buer J, Hansen W: DC-Derived IL-10 Modulates Pro-inflammatory Cytokine Production and Promotes Induction of CD4(+)IL-10(+) Regulatory T Cells during Plasmodium yoelii Infection. Front Immunol 2017, 8:152.
  63. Klein JC, Moses K, Zelinskyy G, Sody S, Buer J, Lang S, Helfrich I, Dittmer U, Kirschning CJ, Brandau S: Combined toll-like receptor 3/7/9 deficiency on host cells results in T-cell-dependent control of tumour growth. Nat Commun 2017, 8:14600.
  64. Kirchhoff L, Olsowski M, Zilmans K, Dittmer S, Haase G, Sedlacek L, Steinmann E, Buer J, Rath PM, Steinmann J: Biofilm formation of the black yeast-like fungus Exophiala dermatitidis and its susceptibility to antiinfective agents. Sci Rep 2017, 7:42886.
  65. Kehrmann J, Veckollari B, Schmidt D, Schildgen O, Schildgen V, Wagner N, Zeschnigk M, Klein-Hitpass L, Witzke O, Buer J, Steinmann J: The lung microbiome in patients with pneumocystosis. BMC Pulm Med 2017, 17(1):170.
  66. Grosse-Onnebrink J, Stehling F, Tschiedel E, Olivier M, Mellies U, Schmidt R, Buer J, Rath PM, Steinmann J: Bacteraemia and fungaemia in cystic fibrosis patients with febrile pulmonary exacerbation: a prospective observational study. BMC Pulm Med 2017, 17(1):96.
  67. Frede A, Neuhaus B, Knuschke T, Wadwa M, Kollenda S, Klopfleisch R, Hansen W, Buer J, Bruder D, Epple M, Westendorf AM: Local delivery of siRNA-loaded calcium phosphate nanoparticles abates pulmonary inflammation. Nanomedicine 2017, 13(8):2395-2403.
  68. Adamczyk A, Gageik D, Frede A, Pastille E, Hansen W, Rueffer A, Buer J, Buning J, Langhorst J, Westendorf AM: Differential expression of GPR15 on T cells during ulcerative colitis. JCI Insight 2017, 2(8)
  69. Wadwa M, Klopfleisch R, Buer J, Westendorf AM: Targeting Antigens to Dec-205 on Dendritic Cells Induces Immune Protection in Experimental Colitis in Mice. Eur J Microbiol Immunol (Bp) 2016, 6(1):1-8.
  70. Wadwa M, Klopfleisch R, Adamczyk A, Frede A, Pastille E, Mahnke K, Hansen W, Geffers R, Lang KS, Buer J, Buning J, Westendorf AM: IL-10 downregulates CXCR3 expression on Th1 cells and interferes with their migration to intestinal inflammatory sites. Mucosal Immunol 2016, 9(5):1263-1277.
  71. Troger B, Hartel C, Buer J, Dordelmann M, Felderhoff-Muser U, Hohn T, Hepping N, Hillebrand G, Kribs A, Marissen J, Olbertz D, Rath PM, Schmidtke S, Siegel J, Herting E, Gopel W, Steinmann J, Stein A: Clinical Relevance of Pathogens Detected by Multiplex PCR in Blood of Very-Low-Birth Weight Infants with Suspected Sepsis - Multicentre Study of the German Neonatal Network. PLoS One 2016, 11(7):e0159821.
  72. Steinmann J, Dittmer S, Houbraken J, Buer J, Rath PM: In Vitro Activity of Isavuconazole against Rasamsonia Species. Antimicrob Agents Chemother 2016, 60(11):6890-6891.
  73. Steinmann J, Buer J, Rath PM: Detection of Aspergillus fumigatus in Blood Samples from Critically Ill Patients in Intensive Care Units by Use of the SeptiFast Assay. J Clin Microbiol 2016, 54(7):1918-1921.
  74. Krull M, Klare I, Ross B, Trenschel R, Beelen DW, Todt D, Steinmann E, Buer J, Rath PM, Steinmann J: Emergence of linezolid- and vancomycin-resistant Enterococcus faecium in a department for hematologic stem cell transplantation. Antimicrob Resist Infect Control 2016, 5:31.
  75. Knuschke T, Rotan O, Bayer W, Sokolova V, Hansen W, Sparwasser T, Dittmer U, Epple M, Buer J, Westendorf AM: Combination of nanoparticle-based therapeutic vaccination and transient ablation of regulatory T cells enhances anti-viral immunity during chronic retroviral infection. Retrovirology 2016, 13:24.
  76. Klotz U, Schmidt D, Willinger B, Steinmann E, Buer J, Rath PM, Steinmann J: Echinocandin resistance and population structure of invasive Candida glabrata isolates from two university hospitals in Germany and Austria. Mycoses 2016, 59(5):312-318.
  77. Kehrmann J, Wessel S, Murali R, Hampel A, Bange FC, Buer J, Mosel F: Principal component analysis of MALDI TOF MS mass spectra separates M. abscessus (sensu stricto) from M. massiliense isolates. BMC Microbiol 2016, 16:24.
  78. Kehrmann J, Schoerding AK, Murali R, Wessel S, Koehling HL, Mosel F, Buer J: Performance of Vitek MS in identifying nontuberculous mycobacteria from MGIT liquid medium and Lowenstein-Jensen solid medium. Diagn Microbiol Infect Dis 2016, 84(1):43-47.
  79. Kehrmann J, Kurt N, Rueger K, Bange FC, Buer J: GenoType NTM-DR for Identifying Mycobacterium abscessus Subspecies and Determining Molecular Resistance. J Clin Microbiol 2016, 54(6):1653-1655.
  80. Gollnick HP, Buer J, Beissert S, Sunderkatter C: Verantwortlicher Umgang mit Antibiotika: Notwendigkeit der Antibiotikareduktion in der Aknetherapie. J Dtsch Dermatol Ges 2016, 14(12):1319-1327.
  81. Gamrad L, Rehbock C, Westendorf AM, Buer J, Barcikowski S, Hansen W: Efficient nucleic acid delivery to murine regulatory T cells by gold nanoparticle conjugates. Sci Rep 2016, 6:28709.
  82. Frede A, Neuhaus B, Klopfleisch R, Walker C, Buer J, Muller W, Epple M, Westendorf AM: Colonic gene silencing using siRNA-loaded calcium phosphate/PLGA nanoparticles ameliorates intestinal inflammation in vivo. J Control Release 2016, 222:86-96.
  83. Abel S, Ueffing K, Tatura R, Hutzler M, Hose M, Matuschewski K, Kehrmann J, Westendorf AM, Buer J, Hansen W: Plasmodium yoelii infection of BALB/c mice results in expansion rather than induction of CD4(+) Foxp3(+) regulatory T cells. Immunology 2016, 148(2):197-205.
  84. Tatura R, Zeschnigk M, Hansen W, Steinmann J, Vidigal PG, Hutzler M, Pastille E, Westendorf AM, Buer J, Kehrmann J: Relevance of Foxp3(+) regulatory T cells for early and late phases of murine sepsis. Immunology 2015, 146(1):144-156.
  85. Steinmann J, Hamprecht A, Vehreschild MJ, Cornely OA, Buchheidt D, Spiess B, Koldehoff M, Buer J, Meis JF, Rath PM: Emergence of azole-resistant invasive aspergillosis in HSCT recipients in Germany. J Antimicrob Chemother 2015, 70(5):1522-1526.
  86. Seiffart V, Zoeller J, Klopfleisch R, Wadwa M, Hansen W, Buer J, Riedel C, Westendorf AM: IL10-Deficiency in CD4(+) T Cells Exacerbates the IFNgamma and IL17 Response During Bacteria Induced Colitis. Cell Physiol Biochem 2015, 36(4):1259-1273.
  87. Rath PM, Schoch B, Adamzik M, Steinmann E, Buer J, Steinmann J: Reply: PCR assay for pathogen detection in ventriculostomy-related meningitis in neurosurgery patients: unanswered questions? Infection 2015, 43(2):251-252.
  88. Niezold T, Storcksdieck Genannt Bonsmann M, Maaske A, Temchura V, Heinecke V, Hannaman D, Buer J, Ehrhardt C, Hansen W, Uberla K, Tenbusch M: DNA vaccines encoding DEC205-targeted antigens: immunity or tolerance? Immunology 2015, 145(4):519-533.
  89. Kruger A, Oldenburg M, Chebrolu C, Beisser D, Kolter J, Sigmund AM, Steinmann J, Schafer S, Hochrein H, Rahmann S, Wagner H, Henneke P, Hornung V, Buer J, Kirschning CJ: Human TLR8 senses UR/URR motifs in bacterial and mitochondrial RNA. EMBO Rep 2015, 16(12):1656-1663.
  90. Koehling HL, Willinger B, Buer J, Rath PM, Steinmann J: Comparative evaluation of a new commercial colorimetric microdilution assay (SensiQuattro Candida EU) with MIC test strip and EUCAST broth microdilution methods for susceptibility testing of invasive Candida isolates. J Clin Microbiol 2015, 53(1):255-261.
  91. Chebrolu C, Artner D, Sigmund AM, Buer J, Zamyatina A, Kirschning CJ: Species and mediator specific TLR4 antagonism in primary human and murine immune cells by betaGlcN(1<-->1)alphaGlc based lipid A mimetics. Mol Immunol 2015, 67(2 Pt B):636-641.
  92. Vidigal PG, Musken M, Becker KA, Haussler S, Wingender J, Steinmann E, Kehrmann J, Gulbins E, Buer J, Rath PM, Steinmann J: Effects of green tea compound epigallocatechin-3-gallate against Stenotrophomonas maltophilia infection and biofilm. PLoS One 2014, 9(4):e92876.
  93. Vidigal PG, Mosel F, Koehling HL, Mueller KD, Buer J, Rath PM, Steinmann J: Delineation of Stenotrophomonas maltophilia isolates from cystic fibrosis patients by fatty acid methyl ester profiles and matrix-assisted laser desorption/ionization time-of-flight mass spectra using hierarchical cluster analysis and principal component analysis. J Med Microbiol 2014, 63(Pt 12):1615-1620.
  94. Vidigal PG, Dittmer S, Steinmann E, Buer J, Rath PM, Steinmann J: Adaptation of Stenotrophomonas maltophilia in cystic fibrosis: molecular diversity, mutation frequency and antibiotic resistance. Int J Med Microbiol 2014, 304(5-6):613-619.
  95. Steinmann J, Giraud S, Schmidt D, Sedlacek L, Hamprecht A, Houbraken J, Meis JF, Bouchara JP, Buer J, Rath PM: Validation of a novel real-time PCR for detecting Rasamsonia argillacea species complex in respiratory secretions from cystic fibrosis patients. New Microbes New Infect 2014, 2(3):72-78.
  96. Ross B, Steinmann J, Buer J, Dusse F, Jakob H, Schneemann H, Hugo-Hanke S, Brautigam S, Sanewski A, Kundt R, Parohl N, Weidler K, Witzke O, Popp W: [Outbreak with Ralstonia pickettii caused by contaminated magnesium vials]. Dtsch Med Wochenschr 2014, 139(7):323-326.
  97. Rath PM, Schoch B, Adamzik M, Steinmann E, Buer J, Steinmann J: Value of multiplex PCR using cerebrospinal fluid for the diagnosis of ventriculostomy-related meningitis in neurosurgery patients. Infection 2014, 42(4):621-627.
  98. Pastille E, Bardini K, Fleissner D, Adamczyk A, Frede A, Wadwa M, von Smolinski D, Kasper S, Sparwasser T, Gruber AD, Schuler M, Sakaguchi S, Roers A, Muller W, Hansen W, Buer J, Westendorf AM: Transient ablation of regulatory T cells improves antitumor immunity in colitis-associated colon cancer. Cancer Res 2014, 74(16):4258-4269.
  99. Langhorst J, Frede A, Knott M, Pastille E, Buer J, Dobos GJ, Westendorf AM: Distinct kinetics in the frequency of peripheral CD4+ T cells in patients with ulcerative colitis experiencing a flare during treatment with mesalazine or with a herbal preparation of myrrh, chamomile, and coffee charcoal. PLoS One 2014, 9(8):e104257.
  100. Kozlova D, Sokolova V, Zhong M, Zhang E, Yang J, Li W, Yang Y, Buer J, Westendorf AM, Epple M, Yan H: Calcium phosphate nanoparticles show an effective activation of the innate immune response in vitro and in vivo after functionalization with flagellin. Virol Sin 2014, 29(1):33-39.
  101. Knuschke T, Bayer W, Rotan O, Sokolova V, Wadwa M, Kirschning CJ, Hansen W, Dittmer U, Epple M, Buer J, Westendorf AM: Prophylactic and therapeutic vaccination with a nanoparticle-based peptide vaccine induces efficient protective immunity during acute and chronic retroviral infection. Nanomedicine 2014, 10(8):1787-1798.
  102. Kehrmann J, Tatura R, Zeschnigk M, Probst-Kepper M, Geffers R, Steinmann J, Buer J: Impact of 5-aza-2'-deoxycytidine and epigallocatechin-3-gallate for induction of human regulatory T cells. Immunology 2014, 142(3):384-395.
  103. Jost NH, Abel S, Hutzler M, Sparwasser T, Zimmermann A, Roers A, Muller W, Klopfleisch R, Hengel H, Westendorf AM, Buer J, Hansen W: Regulatory T cells and T-cell-derived IL-10 interfere with effective anti-cytomegalovirus immune response. Immunol Cell Biol 2014, 92(10):860-871.
  104. Jockenhofer F, Chapot V, Stoffels-Weindorf M, Korber A, Klode J, Buer J, Kupper B, Roesch A, Dissemond J: Bacterial spectrum colonizing chronic leg ulcers: a 10-year comparison from a German wound care center. J Dtsch Dermatol Ges 2014, 12(12):1121-1127.
  105. Herz J, Hagen SI, Bergmuller E, Sabellek P, Gothert JR, Buer J, Hansen W, Hermann DM, Doeppner TR: Exacerbation of ischemic brain injury in hypercholesterolemic mice is associated with pronounced changes in peripheral and cerebral immune responses. Neurobiol Dis 2014, 62:456-468.
  106. Al Ghazal P, Korber A, Klode J, Schmid EN, Buer J, Dissemond J: Evaluation of the Essen Rotary as a new technique for bacterial swabs: results of a prospective controlled clinical investigation in 50 patients with chronic leg ulcers. Int Wound J 2014, 11(1):44-49.
  107. Steinmann J, Buer J, Pietschmann T, Steinmann E: Anti-infective properties of epigallocatechin-3-gallate (EGCG), a component of green tea. Br J Pharmacol 2013, 168(5):1059-1073.
  108. Sokolova V, Kozlova D, Knuschke T, Buer J, Westendorf AM, Epple M: Mechanism of the uptake of cationic and anionic calcium phosphate nanoparticles by cells. Acta Biomater 2013, 9(7):7527-7535.
  109. Schemuth H, Dittmer S, Lackner M, Sedlacek L, Hamprecht A, Steinmann E, Buer J, Rath PM, Steinmann J: In vitro activity of colistin as single agent and in combination with antifungals against filamentous fungi occurring in patients with cystic fibrosis. Mycoses 2013, 56(3):297-303.
  110. Knuschke T, Sokolova V, Rotan O, Wadwa M, Tenbusch M, Hansen W, Staeheli P, Epple M, Buer J, Westendorf AM: Immunization with biodegradable nanoparticles efficiently induces cellular immunity and protects against influenza virus infection. J Immunol 2013, 190(12):6221-6229.
  111. Goncalves Vidigal P, Schmidt D, Stehling F, Mellies U, Steinmann E, Buer J, Rath PM, Steinmann J: Development of a quantitative immunofluorescence assay for detection of Stenotrophomonas maltophilia antibodies in patients with cystic fibrosis. J Cyst Fibros 2013, 12(6):651-654.
  112. Tschiedel E, Steinmann J, Buer J, Onnebrink JG, Felderhoff-Muser U, Rath PM, Dohna-Schwake C: Results and relevance of molecular detection of pathogens by SeptiFast--a retrospective analysis in 75 critically ill children. Klin Padiatr 2012, 224(1):12-16.
  113. Tosiek MJ, Bader SR, Gruber AD, Buer J, Gereke M, Bruder D: CD8(+) T cells responding to alveolar self-antigen lack CD25 expression and fail to precipitate autoimmunity. Am J Respir Cell Mol Biol 2012, 47(6):869-878.
  114. Tatura R, Zeschnigk M, Adamzik M, Probst-Kepper M, Buer J, Kehrmann J: Quantification of regulatory T cells in septic patients by real-time PCR-based methylation assay and flow cytometry. PLoS One 2012, 7(11):e49962.
  115. Ross B, Witzke O, Kribben A, Heintschel von Heinegg E, Buer J, Gerken G, Fiedler M, Popp W: [Managing EHEC in hospital routine]. Dtsch Med Wochenschr 2012, 137(18):933-936.
  116. Riss GL, Chang DI, Wevers C, Westendorf AM, Buer J, Scherbaum N, Hansen W: Opioid maintenance therapy restores CD4+ T cell function by normalizing CD4+CD25(high) regulatory T cell frequencies in heroin user. Brain Behav Immun 2012, 26(6):972-978.
  117. Rath PM, Saner F, Paul A, Lehmann N, Steinmann E, Buer J, Steinmann J: Multiplex PCR for rapid and improved diagnosis of bloodstream infections in liver transplant recipients. J Clin Microbiol 2012, 50(6):2069-2071.
  118. Rath PM, Buchheidt D, Spiess B, Arfanis E, Buer J, Steinmann J: First reported case of azole-resistant aspergillus fumigatus due to the TR/L98H mutation in Germany. Antimicrob Agents Chemother 2012, 56(11):6060-6061.
  119. Oldenburg M, Kruger A, Ferstl R, Kaufmann A, Nees G, Sigmund A, Bathke B, Lauterbach H, Suter M, Dreher S, Koedel U, Akira S, Kawai T, Buer J, Wagner H, Bauer S, Hochrein H, Kirschning CJ: TLR13 recognizes bacterial 23S rRNA devoid of erythromycin resistance-forming modification. Science 2012, 337(6098):1111-1115.
  120. Metz CH, Buer J, Bornfeld N, Lipski A: Bilateral Bartonella henselae neuroretinitis with stellate maculopathy in a 6-year-old boy. Infection 2012, 40(2):191-194.
  121. Kozlova D, Chernousova S, Knuschke T, Buer J, Westendorf AM, Epple M: Cell targeting by antibody-functionalized calcium phosphate nanoparticles. J Mater Chem 2012, 22(2):396-404.
  122. Kohling HL, Bittner A, Muller KD, Buer J, Becker M, Rubben H, Rettenmeier AW, Mosel F: Direct identification of bacteria in urine samples by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry and relevance of defensins as interfering factors. J Med Microbiol 2012, 61(Pt 3):339-344.
  123. Jeron A, Hansen W, Ewert F, Buer J, Geffers R, Bruder D: ChIP-on-chip analysis identifies IL-22 as direct target gene of ectopically expressed FOXP3 transcription factor in human T cells. BMC Genomics 2012, 13:705.
  124. Heintschel von Heinegg E, Steinmann J, Buer J, Rath P: Infektionen durch Pilze. In: Labor und Diagnose. Edited by Thomas L, 8 edn: TH-Books; 2012: 2127-2143.
  125. Hansen W, Hutzler M, Abel S, Alter C, Stockmann C, Kliche S, Albert J, Sparwasser T, Sakaguchi S, Westendorf AM, Schadendorf D, Buer J, Helfrich I: Neuropilin 1 deficiency on CD4+Foxp3+ regulatory T cells impairs mouse melanoma growth. J Exp Med 2012, 209(11):2001-2016.
  126. Abel S, Luckheide N, Westendorf AM, Geffers R, Roers A, Muller W, Sparwasser T, Matuschewski K, Buer J, Hansen W: Strong impact of CD4+ Foxp3+ regulatory T cells and limited effect of T cell-derived IL-10 on pathogen clearance during Plasmodium yoelii infection. J Immunol 2012, 188(11):5467-5477.
  127. Tosiek MJ, Gruber AD, Bader SR, Mauel S, Hoymann HG, Prettin S, Tschernig T, Buer J, Gereke M, Bruder D: CD4+CD25+Foxp3+ regulatory T cells are dispensable for controlling CD8+ T cell-mediated lung inflammation. J Immunol 2011, 186(11):6106-6118.
  128. Steinmann J, Schmidt D, Buer J, Rath PM: Discrimination of Scedosporium prolificans against Pseudallescheria boydii and Scedosporium apiospermum by semiautomated repetitive sequence-based PCR. Med Mycol 2011, 49(5):475-483.
  129. Steinmann J, Kaase M, Gatermann S, Popp W, Steinmann E, Damman M, Paul A, Saner F, Buer J, Rath P: Outbreak due to a Klebsiella pneumoniae strain harbouring KPC-2 and VIM-1 in a German university hospital, July 2010 to January 2011. Euro Surveill 2011, 16(33).
  130. Steinmann J, Huelsewede J, Buer J, Rath PM: Comparison and evaluation of a novel bioassay and high-performance liquid chromatography for the clinical measurement of serum voriconazole concentrations. Mycoses 2011, 54(5):e421-428.
  131. Sokolova V, Knuschke T, Buer J, Westendorf AM, Epple M: Quantitative determination of the composition of multi-shell calcium phosphate-oligonucleotide nanoparticles and their application for the activation of dendritic cells. Acta Biomater 2011, 7(11):4029-4036.
  132. Schenk U, Frascoli M, Proietti M, Geffers R, Traggiai E, Buer J, Ricordi C, Westendorf AM, Grassi F: ATP inhibits the generation and function of regulatory T cells through the activation of purinergic P2X receptors. Sci Signal 2011, 4(162):ra12.
  133. Lipski A, Buer J, Bornfeld N, Metz C: Katzenkrankheit - ein dicker Floh im Heuhaufen? . Z prakt Augenheilkd 2011, 32:409-412.
  134. Kehrmann J, Zeschnigk M, Buer J, Probst-Kepper M: FOXP3 Expression in GARP-Transduced Helper T Cells Is Not Associated with FOXP3 TSDR Demethylation. Transfus Med Hemother 2011, 38(5):287-291.
  135. Kehrmann J, Kaase M, Szabados F, Gatermann SG, Buer J, Rath PM, Steinmann J: Vancomycin MIC creep in MRSA blood culture isolates from Germany: a regional problem? Eur J Clin Microbiol Infect Dis 2011, 30(5):677-683.
  136. Goncalves-Vidigal P, Grosse-Onnebrink J, Mellies U, Buer J, Rath PM, Steinmann J: Stenotrophomonas maltophilia in cystic fibrosis: improved detection by the use of selective agar and evaluation of antimicrobial resistance. J Cyst Fibros 2011, 10(6):422-427.
  137. Fleissner D, Loser K, Hansen W, Dissemond J, Korber A, Beissert S, Buer J, Westendorf AM: In vitro induced CD8+ regulatory T cells inhibit skin inflammation. Eur J Microbiol Immunol (Bp) 2011, 1(3):208-214.
  138. Fleissner D, Frede A, Knott M, Knuschke T, Geffers R, Hansen W, Dobos G, Langhorst J, Buer J, Westendorf AM: Generation and function of immunosuppressive human and murine CD8+ T cells by transforming growth factor-beta and retinoic acid. Immunology 2011, 134(1):82-92.
  139. Westendorf AM, Fleissner D, Hansen W, Buer J: T cells, dendritic cells and epithelial cells in intestinal homeostasis. Int J Med Microbiol 2010, 300(1):11-18.
  140. Vernadakis S, Adamzik M, Heuer M, Antoch G, Baba H, Fiedler M, Buer J, Paul A, Kaiser GM: [Hemicolectomy for ischemic colitis : A case report of a (H1N1) virus-associated death]. Chirurg 2010, 81(9):841-845.
  141. Trunk K, Benkert B, Quack N, Munch R, Scheer M, Garbe J, Jansch L, Trost M, Wehland J, Buer J, Jahn M, Schobert M, Jahn D: Anaerobic adaptation in Pseudomonas aeruginosa: definition of the Anr and Dnr regulons. Environ Microbiol 2010, 12(6):1719-1733.
  142. Steinmann J, Buer J, Rath PM: Caspofungin: cross-reactivity in the Aspergillus antigen assay. J Clin Microbiol 2010, 48(6):2313.
  143. Sokolova V, Knuschke T, Kovtun A, Buer J, Epple M, Westendorf AM: The use of calcium phosphate nanoparticles encapsulating Toll-like receptor ligands and the antigen hemagglutinin to induce dendritic cell maturation and T cell activation. Biomaterials 2010, 31(21):5627-5633.
  144. Probst-Kepper M, Buer J: FOXP3 and GARP (LRRC32): the master and its minion. Biol Direct 2010, 5:8.
  145. Probst-Kepper M, Balling R, Buer J: FOXP3: required but not sufficient. the role of GARP (LRRC32) as a safeguard of the regulatory phenotype. Curr Mol Med 2010, 10(6):533-539.
  146. Popp W, Buer J, Rath P-M, Steinmann J, Kundt R, Scheytt C, Hansen D: MRSA - aktuelle Entwicklungen, drängende Probleme. Krh-Hyg + Infverh 2010, 32(5):144-150.
  147. Menning A, Loddenkemper C, Westendorf AM, Szilagyi B, Buer J, Siewert C, Hamann A, Huehn J: Retinoic acid-induced gut tropism improves the protective capacity of Treg in acute but not in chronic gut inflammation. Eur J Immunol 2010, 40(9):2539-2548.
  148. Korber A, Schmid EN, Buer J, Klode J, Schadendorf D, Dissemond J: Bacterial colonization of chronic leg ulcers: current results compared with data 5 years ago in a specialized dermatology department. J Eur Acad Dermatol Venereol 2010, 24(9):1017-1025.
  149. Hansen W, Westendorf AM, Toepfer T, Mauel S, Geffers R, Gruber AD, Buer J: Inflammation in vivo is modulated by GPR83 isoform-4 but not GPR83 isoform-1 expression in regulatory T cells. Genes Immun 2010, 11(4):357-361.
  150. Fleissner D, Hansen W, Geffers R, Buer J, Westendorf AM: Local induction of immunosuppressive CD8+ T cells in the gut-associated lymphoid tissues. PLoS One 2010, 5(10):e15373.
  151. Bar-On L, Birnberg T, Lewis KL, Edelson BT, Bruder D, Hildner K, Buer J, Murphy KM, Reizis B, Jung S: CX3CR1+ CD8alpha+ dendritic cells are a steady-state population related to plasmacytoid dendritic cells. Proc Natl Acad Sci U S A 2010, 107(33):14745-14750.
  152. Westendorf AM, Fleissner D, Groebe L, Jung S, Gruber AD, Hansen W, Buer J: CD4+Foxp3+ regulatory T cell expansion induced by antigen-driven interaction with intestinal epithelial cells independent of local dendritic cells. Gut 2009, 58(2):211-219.
  153. Walter UB, J.: Single cell immunology. In: Single cell analysis - Technologies and applications. Edited by Anselmetti D. Weinheim: Wiley-VCH; 2009: 175-196.
  154. Ukena SN, Koenecke C, Geffers R, Fuehner T, Welte T, Ganser A, Buer J, Franzke A: T helper type 2 differentiation is associated with induction of antibacterial defense mechanisms in blood lymphocytes of patients with sarcoidosis. Immunol Invest 2009, 38(1):49-66.
  155. TrehanPati N, Geffers R, Sukriti, Hissar S, Riese P, Toepfer T, Buer J, Kumar M, Guzman CA, Sarin SK: Gene expression signatures of peripheral CD4+ T cells clearly discriminate between patients with acute and chronic hepatitis B infection. Hepatology 2009, 49(3):781-790.
  156. Steinmann J, Marggraf G, Buer J, Rath PM: Syphilis-specific immunoglobulin G seroconversion after double-lung transplantation. J Heart Lung Transplant 2009, 28(8):857-859.
  157. Steinmann J, Buer J, Rath PM, Paul A, Saner F: Invasive aspergillosis in two liver transplant recipients: diagnosis by SeptiFast. Transpl Infect Dis 2009, 11(2):175-178.
  158. Stark L, Matussek A, Strindhall J, Geffers R, Buer J, Kihlstrom E, Monnecke S, Lofgren S, Lindgren PE: Staphylococcus aureus isolates from blood and anterior nares induce similar innate immune responses in endothelial cells. APMIS 2009, 117(11):814-824.
  159. Probst-Kepper M, Kroger A, Garritsen HS, Buer J: Perspectives on Regulatory T Cell Therapies. Transfus Med Hemother 2009, 36(5):302-308.
  160. Probst-Kepper M, Geffers R, Kroger A, Viegas N, Erck C, Hecht HJ, Lunsdorf H, Roubin R, Moharregh-Khiabani D, Wagner K, Ocklenburg F, Jeron A, Garritsen H, Arstila TP, Kekalainen E, Balling R, Hauser H, Buer J, Weiss S: GARP: a key receptor controlling FOXP3 in human regulatory T cells. J Cell Mol Med 2009, 13(9B):3343-3357.
  161. Lahl K, Mayer CT, Bopp T, Huehn J, Loddenkemper C, Eberl G, Wirnsberger G, Dornmair K, Geffers R, Schmitt E, Buer J, Sparwasser T: Nonfunctional regulatory T cells and defective control of Th2 cytokine production in natural scurfy mutant mice. J Immunol 2009, 183(9):5662-5672.
  162. Jeron A, Pfoertner S, Bruder D, Geffers R, Hammerer P, Hofmann R, Buer J, Schrader AJ: Frequency and gene expression profile of regulatory T cells in renal cell carcinoma. Tumour Biol 2009, 30(3):160-170.
  163. Gereke M, Jung S, Buer J, Bruder D: Alveolar type II epithelial cells present antigen to CD4(+) T cells and induce Foxp3(+) regulatory T cells. Am J Respir Crit Care Med 2009, 179(5):344-355.
  164. de Buhr MF, Hedrich HJ, Westendorf AM, Obermeier F, Hofmann C, Zschemisch NH, Buer J, Bumann D, Goyert SM, Bleich A: Analysis of Cd14 as a genetic modifier of experimental inflammatory bowel disease (IBD) in mice. Inflamm Bowel Dis 2009, 15(12):1824-1836.
  165. Veldhoen M, Uyttenhove C, van Snick J, Helmby H, Westendorf A, Buer J, Martin B, Wilhelm C, Stockinger B: Transforming growth factor-beta 'reprograms' the differentiation of T helper 2 cells and promotes an interleukin 9-producing subset. Nat Immunol 2008, 9(12):1341-1346.
  166. Veldhoen M, Hirota K, Westendorf AM, Buer J, Dumoutier L, Renauld JC, Stockinger B: The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins. Nature 2008, 453(7191):106-109.
  167. Seifert O, Bayat A, Geffers R, Dienus K, Buer J, Lofgren S, Matussek A: Identification of unique gene expression patterns within different lesional sites of keloids. Wound Repair Regen 2008, 16(2):254-265.
  168. Schenk U, Westendorf AM, Radaelli E, Casati A, Ferro M, Fumagalli M, Verderio C, Buer J, Scanziani E, Grassi F: Purinergic control of T cell activation by ATP released through pannexin-1 hemichannels. Sci Signal 2008, 1(39):ra6.
  169. Reinwald S, Wiethe C, Westendorf AM, Breloer M, Probst-Kepper M, Fleischer B, Steinkasserer A, Buer J, Hansen W: CD83 expression in CD4+ T cells modulates inflammation and autoimmunity. J Immunol 2008, 180(9):5890-5897.
  170. Nickeleit I, Zender S, Sasse F, Geffers R, Brandes G, Sorensen I, Steinmetz H, Kubicka S, Carlomagno T, Menche D, Gutgemann I, Buer J, Gossler A, Manns MP, Kalesse M, Frank R, Malek NP: Argyrin a reveals a critical role for the tumor suppressor protein p27(kip1) in mediating antitumor activities in response to proteasome inhibition. Cancer Cell 2008, 14(1):23-35.
  171. Hansen W, Westendorf AM, Buer J: Regulatory T cells as targets for immunotherapy of autoimmunity and inflammation. Inflamm Allergy Drug Targets 2008, 7(4):217-223.
  172. Haile LA, von Wasielewski R, Gamrekelashvili J, Kruger C, Bachmann O, Westendorf AM, Buer J, Liblau R, Manns MP, Korangy F, Greten TF: Myeloid-derived suppressor cells in inflammatory bowel disease: a new immunoregulatory pathway. Gastroenterology 2008, 135(3):871-881, 881 e871-875.
  173. Gustafsson C, Mjosberg J, Matussek A, Geffers R, Matthiesen L, Berg G, Sharma S, Buer J, Ernerudh J: Gene expression profiling of human decidual macrophages: evidence for immunosuppressive phenotype. PLoS One 2008, 3(4):e2078.
  174. Ukena SN, Singh A, Dringenberg U, Engelhardt R, Seidler U, Hansen W, Bleich A, Bruder D, Franzke A, Rogler G, Suerbaum S, Buer J, Gunzer F, Westendorf AM: Probiotic Escherichia coli Nissle 1917 inhibits leaky gut by enhancing mucosal integrity. PLoS One 2007, 2(12):e1308.
  175. Stecher B, Robbiani R, Walker AW, Westendorf AM, Barthel M, Kremer M, Chaffron S, Macpherson AJ, Buer J, Parkhill J, Dougan G, von Mering C, Hardt WD: Salmonella enterica serovar typhimurium exploits inflammation to compete with the intestinal microbiota. PLoS Biol 2007, 5(10):2177-2189.
  176. Schrader AJ, Hegele A, Olbert P, Buer J, Jeron A, Hofmann R: [Application monitoring of the use of sorafenib in papillary renal cell carcinoma]. Urologe A 2007, 46(9):1291.
  177. McMillan DJ, Geffers R, Buer J, Vlaminckx BJ, Sriprakash KS, Chhatwal GS: Variations in the distribution of genes encoding virulence and extracellular proteins in group A streptococcus are largely restricted to 11 genomic loci. Microbes Infect 2007, 9(3):259-270.
  178. Masse GX, Corcuff E, Decaluwe H, Bommhardt U, Lantz O, Buer J, Di Santo JP: gamma(c) cytokines provide multiple homeostatic signals to naive CD4(+) T cells. Eur J Immunol 2007, 37(9):2606-2616.
  179. Jablonska J, Dittmar KE, Kleinke T, Buer J, Weiss S: Essential role of CCL2 in clustering of splenic ERTR-9+ macrophages during infection of BALB/c mice by Listeria monocytogenes. Infect Immun 2007, 75(1):462-470. 
  180. He F, Buer J, Zeng AP, Balling R: Dynamic cumulative activity of transcription factors as a mechanism of quantitative gene regulation. Genome Biol 2007, 8(9):R181.
  181. Hansen W, Westendorf AM, Reinwald S, Bruder D, Deppenmeier S, Groebe L, Probst-Kepper M, Gruber AD, Geffers R, Buer J: Chronic antigen stimulation in vivo induces a distinct population of antigen-specific Foxp3 CD25 regulatory T cells. J Immunol 2007, 179(12):8059-8068.
  182. Gereke M, Grobe L, Prettin S, Kasper M, Deppenmeier S, Gruber AD, Enelow RI, Buer J, Bruder D: Phenotypic alterations in type II alveolar epithelial cells in CD4+ T cell mediated lung inflammation. Respir Res 2007, 8:47.
  183. Choudhury AR, Ju Z, Djojosubroto MW, Schienke A, Lechel A, Schaetzlein S, Jiang H, Stepczynska A, Wang C, Buer J, Lee HW, von Zglinicki T, Ganser A, Schirmacher P, Nakauchi H, Rudolph KL: Cdkn1a deletion improves stem cell function and lifespan of mice with dysfunctional telomeres without accelerating cancer formation. Nat Genet 2007, 39(1):99-105.
  184. Bohn G, Allroth A, Brandes G, Thiel J, Glocker E, Schaffer AA, Rathinam C, Taub N, Teis D, Zeidler C, Dewey RA, Geffers R, Buer J, Huber LA, Welte K, Grimbacher B, Klein C: A novel human primary immunodeficiency syndrome caused by deficiency of the endosomal adaptor protein p14. Nat Med 2007, 13(1):38-45.
  185. Westendorf AM, Fleissner D, Deppenmeier S, Gruber AD, Bruder D, Hansen W, Liblau R, Buer J: Autoimmune-mediated intestinal inflammation-impact and regulation of antigen-specific CD8+ T cells. Gastroenterology 2006, 131(2):510-524.
  186. Westendorf AM, Bruder D, Hansen W, Buer J: Intestinal epithelial antigen induces CD4+ T cells with regulatory phenotype in a transgenic autoimmune mouse model. Ann N Y Acad Sci 2006, 1072:401-406.
  187. Wendt K, Wilk E, Buyny S, Buer J, Schmidt RE, Jacobs R: Gene and protein characteristics reflect functional diversity of CD56dim and CD56bright NK cells. J Leukoc Biol 2006, 80(6):1529-1541.
  188. Veldman C, Pahl A, Beissert S, Hansen W, Buer J, Dieckmann D, Schuler G, Hertl M: Inhibition of the transcription factor Foxp3 converts desmoglein 3-specific type 1 regulatory T cells into Th2-like cells. J Immunol 2006, 176(5):3215-3222.
  189. Timmerbeul I, Garrett-Engele CM, Kossatz U, Chen X, Firpo E, Grunwald V, Kamino K, Wilkens L, Lehmann U, Buer J, Geffers R, Kubicka S, Manns MP, Porter PL, Roberts JM, Malek NP: Testing the importance of p27 degradation by the SCFskp2 pathway in murine models of lung and colon cancer. Proc Natl Acad Sci U S A 2006, 103(38):14009-14014.
  190. Schrader AJ, Varga Z, Pfoertner S, Goelden U, Buer J, Hofmann R: Treatment targeted at vascular endothelial growth factor: a promising approach to managing metastatic kidney cancer. BJU Int 2006, 97(3):461-465.
  191. Pfoertner S, Jeron A, Probst-Kepper M, Guzman CA, Hansen W, Westendorf AM, Toepfer T, Schrader AJ, Franzke A, Buer J, Geffers R: Signatures of human regulatory T cells: an encounter with old friends and new players. Genome Biol 2006, 7(7):R54.
  192. Ocklenburg F, Moharregh-Khiabani D, Geffers R, Janke V, Pfoertner S, Garritsen H, Groebe L, Klempnauer J, Dittmar KE, Weiss S, Buer J, Probst-Kepper M: UBD, a downstream element of FOXP3, allows the identification of LGALS3, a new marker of human regulatory T cells. Lab Invest 2006, 86(7):724-737.
  193. Nalca Y, Jansch L, Bredenbruch F, Geffers R, Buer J, Haussler S: Quorum-sensing antagonistic activities of azithromycin in Pseudomonas aeruginosa PAO1: a global approach. Antimicrob Agents Chemother 2006, 50(5):1680-1688.
  194. McMillan DJ, Beiko RG, Geffers R, Buer J, Schouls LM, Vlaminckx BJ, Wannet WJ, Sriprakash KS, Chhatwal GS: Genes for the majority of group a streptococcal virulence factors and extracellular surface proteins do not confer an increased propensity to cause invasive disease. Clin Infect Dis 2006, 43(7):884-891.
  195. Kaps C, Frauenschuh S, Endres M, Ringe J, Haisch A, Lauber J, Buer J, Krenn V, Haupl T, Burmester GR, Sittinger M: Gene expression profiling of human articular cartilage grafts generated by tissue engineering. Biomaterials 2006, 27(19):3617-3630.
  196. Hansen W, Loser K, Westendorf AM, Bruder D, Pfoertner S, Siewert C, Huehn J, Beissert S, Buer J: G protein-coupled receptor 83 overexpression in naive CD4+CD25- T cells leads to the induction of Foxp3+ regulatory T cells in vivo. J Immunol 2006, 177(1):209-215.
  197. Garbe AI, Vermeer B, Gamrekelashvili J, von Wasielewski R, Greten FR, Westendorf AM, Buer J, Schmid RM, Manns MP, Korangy F, Greten TF: Genetically induced pancreatic adenocarcinoma is highly immunogenic and causes spontaneous tumor-specific immune responses. Cancer Res 2006, 66(1):508-516.
  198. Fritzsching B, Oberle N, Pauly E, Geffers R, Buer J, Poschl J, Krammer P, Linderkamp O, Suri-Payer E: Naive regulatory T cells: a novel subpopulation defined by resistance toward CD95L-mediated cell death. Blood 2006, 108(10):3371-3378.
  199. Franzke A, Koenecke C, Geffers R, Piao W, Hunger JK, Ganser A, Buer J: Classical Hodgkin's lymphoma: molecular evidence for specific alterations in circulating T lymphocytes. Tumour Biol 2006, 27(6):329-333.
  200. Franzke A, Hunger JK, Dittmar KE, Ganser A, Buer J: Regulatory T-cells in the control of immunological diseases. Ann Hematol 2006, 85(11):747-758.
  201. Franzke A, Geffers R, Hunger JK, Pfortner S, Piao W, Ivanyi P, Grosse J, Probst-Kepper M, Ganser A, Buer J: Identification of novel regulators in T-cell differentiation of aplastic anemia patients. BMC Genomics 2006, 7:263.
  202. de Buhr MF, Mahler M, Geffers R, Hansen W, Westendorf AM, Lauber J, Buer J, Schlegelberger B, Hedrich HJ, Bleich A: Cd14, Gbp1, and Pla2g2a: three major candidate genes for experimental IBD identified by combining QTL and microarray analyses. Physiol Genomics 2006, 25(3):426-434.
  203. Bredenbruch F, Geffers R, Nimtz M, Buer J, Haussler S: The Pseudomonas aeruginosa quinolone signal (PQS) has an iron-chelating activity. Environ Microbiol 2006, 8(8):1318-1329.
  204. Blumenthal A, Ehlers S, Lauber J, Buer J, Lange C, Goldmann T, Heine H, Brandt E, Reiling N: The Wingless homolog WNT5A and its receptor Frizzled-5 regulate inflammatory responses of human mononuclear cells induced by microbial stimulation. Blood 2006, 108(3):965-973.
  205. Wiemann SU, Satyanarayana A, Buer J, Kamino K, Manns MP, Rudolph KL: Contrasting effects of telomere shortening on organ homeostasis, tumor suppression, and survival during chronic liver damage. Oncogene 2005, 24(9):1501-1509.
  206. Westendorf AM, Templin M, Geffers R, Deppenmeier S, Gruber AD, Probst-Kepper M, Hansen W, Liblau RS, Gunzer F, Bruder D, Buer J: CD4+ T cell mediated intestinal immunity: chronic inflammation versus immune regulation. Gut 2005, 54(1):60-69.
  207. Westendorf AM, Gunzer F, Deppenmeier S, Tapadar D, Hunger JK, Schmidt MA, Buer J, Bruder D: Intestinal immunity of Escherichia coli NISSLE 1917: a safe carrier for therapeutic molecules. FEMS Immunol Med Microbiol 2005, 43(3):373-384.
  208. Ukena SN, Westendorf AM, Hansen W, Rohde M, Geffers R, Coldewey S, Suerbaum S, Buer J, Gunzer F: The host response to the probiotic Escherichia coli strain Nissle 1917: specific up-regulation of the proinflammatory chemokine MCP-1. BMC Med Genet 2005, 6:43.
  209. Sun J, Gunzer F, Westendorf AM, Buer J, Scharfe M, Jarek M, Gossling F, Blocker H, Zeng AP: Genomic peculiarity of coding sequences and metabolic potential of probiotic Escherichia coli strain Nissle 1917 inferred from raw genome data. J Biotechnol 2005, 117(2):147-161.
  210. Salunkhe P, Topfer T, Buer J, Tummler B: Genome-wide transcriptional profiling of the steady-state response of Pseudomonas aeruginosa to hydrogen peroxide. J Bacteriol 2005, 187(8):2565-2572.
  211. Rharbaoui F, Bruder D, Vidakovic M, Ebensen T, Buer J, Guzman CA: Characterization of a B220+ lymphoid cell subpopulation with immune modulatory functions in nasal-associated lymphoid tissues. J Immunol 2005, 174(3):1317-1324.
  212. Rathinam C, Geffers R, Yucel R, Buer J, Welte K, Moroy T, Klein C: The transcriptional repressor Gfi1 controls STAT3-dependent dendritic cell development and function. Immunity 2005, 22(6):717-728.
  213. Priebe-Richter C, Ivanyi P, Buer J, Langer F, Lotz J, Hertenstein B, Ganser A, Franzke A: Inflammatory pseudotumor of the lung following invasive aspergillosis in a patient with chronic graft-vs.-host disease. Eur J Haematol 2005, 75(1):68-72.
  214. Pfoertner S, Goelden U, Hansen W, Toepfer T, Geffers R, Ukena SN, von Knobloch R, Hofmann R, Buer J, Schrader AJ: Cellular retinoic acid binding protein I: expression and functional influence in renal cell carcinoma. Tumour Biol 2005, 26(6):313-323.
  215. Matussek A, Strindhall J, Stark L, Rohde M, Geffers R, Buer J, Kihlstrom E, Lindgren PE, Lofgren S: Infection of human endothelial cells with Staphylococcus aureus induces transcription of genes encoding an innate immunity response. Scand J Immunol 2005, 61(6):536-544.
  216. Loser K, Hansen W, Apelt J, Balkow S, Buer J, Beissert S: In vitro-generated regulatory T cells induced by Foxp3-retrovirus infection control murine contact allergy and systemic autoimmunity. Gene Ther 2005, 12(17):1294-1304.
  217. Lechel A, Satyanarayana A, Ju Z, Plentz RR, Schaetzlein S, Rudolph C, Wilkens L, Wiemann SU, Saretzki G, Malek NP, Manns MP, Buer J, Rudolph KL: The cellular level of telomere dysfunction determines induction of senescence or apoptosis in vivo. EMBO Rep 2005, 6(3):275-281.
  218. Juhas M, Wiehlmann L, Salunkhe P, Lauber J, Buer J, Tummler B: GeneChip expression analysis of the VqsR regulon of Pseudomonas aeruginosa TB. FEMS Microbiol Lett 2005, 242(2):287-295.
  219. Goelden U, Ukena SN, Pfoertner S, Hofmann R, Buer J, Schrader AJ: RAR-beta(1) overexpression in chromophobe renal cell carcinoma: a novel target for therapeutic intervention? Exp Oncol 2005, 27(3):220-224.
  220. Goelden U, Pfoertner S, Hansen W, Toepfer T, von Knobloch R, Hofmann R, Buer J, Schrader AJ: Expression and functional influence of cellular retinoic acid-binding protein II in renal cell carcinoma. Urol Int 2005, 75(3):269-276.
  221. Buer J, Westendorf AM, Zeng A-P, He F, Hansen W, Probst-Kepper M: Mechanisms of central and peripheral T-cell tolerance: An update. Transfus Med Hemother 2005, 32:384-399.
  222. Bruder D, Westendorf AM, Hansen W, Prettin S, Gruber AD, Qian Y, von Boehmer H, Mahnke K, Buer J: On the edge of autoimmunity: T-cell stimulation by steady-state dendritic cells prevents autoimmune diabetes. Diabetes 2005, 54(12):3395-3401.
  223. Blumenthal A, Lauber J, Hoffmann R, Ernst M, Keller C, Buer J, Ehlers S, Reiling N: Common and unique gene expression signatures of human macrophages in response to four strains of Mycobacterium avium that differ in their growth and persistence characteristics. Infect Immun 2005, 73(6):3330-3341.
  224. Walter U, Scherbaum WA, Walter U, Buer J: MHC class II expression by beta cells in Type 1 diabetes: promoting or inhibiting the autoimmune process? A reply to D. W. R. Gray. Diabetologia 2004, 47(9):1641-1642. 
  225. von Gotz F, Haussler S, Jordan D, Saravanamuthu SS, Wehmhoner D, Strussmann A, Lauber J, Attree I, Buer J, Tummler B, Steinmetz I: Expression analysis of a highly adherent and cytotoxic small colony variant of Pseudomonas aeruginosa isolated from a lung of a patient with cystic fibrosis. J Bacteriol 2004, 186(12):3837-3847.
  226. Schrader AJ, von Knobloch R, Heidenreich A, Buer J, Hofmann R: Application of retinoids in the treatment of renal cell carcinoma--a futile effort? Anticancer Drugs 2004, 15(9):819-824.
  227. Satyanarayana A, Greenberg RA, Schaetzlein S, Buer J, Masutomi K, Hahn WC, Zimmermann S, Martens U, Manns MP, Rudolph KL: Mitogen stimulation cooperates with telomere shortening to activate DNA damage responses and senescence signaling. Mol Cell Biol 2004, 24(12):5459-5474.
  228. Satyanarayana A, Geffers R, Manns MP, Buer J, Rudolph KL: Gene expression profile at the G1/S transition of liver regeneration after partial hepatectomy in mice. Cell Cycle 2004, 3(11):1405-1417.
  229. Saravanamuthu SS, von Gotz F, Salunkhe P, Chozhavendan R, Geffers R, Buer J, Tummler B, Steinmetz I: Evidence for polyadenylated mRNA in Pseudomonas aeruginosa. J Bacteriol 2004, 186(20):7015-7018.
  230. Rharbaoui F, Westendorf A, Link C, Felk S, Buer J, Gunzer M, Guzman CA: The Mycoplasma-derived macrophage-activating 2-kilodalton lipopeptide triggers global immune activation on nasal mucosa-associated lymphoid tissues. Infect Immun 2004, 72(12):6978-6986.
  231. Ma HW, Kumar B, Ditges U, Gunzer F, Buer J, Zeng AP: An extended transcriptional regulatory network of Escherichia coli and analysis of its hierarchical structure and network motifs. Nucleic Acids Res 2004, 32(22):6643-6649.
  232. Ma HW, Buer J, Zeng AP: Hierarchical structure and modules in the Escherichia coli transcriptional regulatory network revealed by a new top-down approach. BMC Bioinformatics 2004, 5:199.
  233. Kossatz U, Dietrich N, Zender L, Buer J, Manns MP, Malek NP: Skp2-dependent degradation of p27kip1 is essential for cell cycle progression. Genes Dev 2004, 18(21):2602-2607.
  234. Keller C, Lauber J, Blumenthal A, Buer J, Ehlers S: Resistance and susceptibility to tuberculosis analysed at the transcriptome level: lessons from mouse macrophages. Tuberculosis (Edinb) 2004, 84(3-4):144-158.
  235. Huehn J, Siegmund K, Lehmann JC, Siewert C, Haubold U, Feuerer M, Debes GF, Lauber J, Frey O, Przybylski GK, Niesner U, de la Rosa M, Schmidt CA, Brauer R, Buer J, Scheffold A, Hamann A: Developmental stage, phenotype, and migration distinguish naive- and effector/memory-like CD4+ regulatory T cells. J Exp Med 2004, 199(3):303-313.
  236. Hansen W, Buer J: Role of regulatory T cells for the outcome of allo- and autoimmune responses. Transfus Med Hemother 2004, 31:322-331.
  237. Eschbach M, Schreiber K, Trunk K, Buer J, Jahn D, Schobert M: Long-term anaerobic survival of the opportunistic pathogen Pseudomonas aeruginosa via pyruvate fermentation. J Bacteriol 2004, 186(14):4596-4604.
  238. Bruder D, Westendorf AM, Geffers R, Gruber AD, Gereke M, Enelow RI, Buer J: CD4 T Lymphocyte-mediated lung disease: steady state between pathological and tolerogenic immune reactions. Am J Respir Crit Care Med 2004, 170(11):1145-1152.
  239. Bruder D, Probst-Kepper M, Westendorf AM, Geffers R, Beissert S, Loser K, von Boehmer H, Buer J, Hansen W: Neuropilin-1: a surface marker of regulatory T cells. Eur J Immunol 2004, 34(3):623-630.
  240. Bohn E, Muller S, Lauber J, Geffers R, Speer N, Spieth C, Krejci J, Manncke B, Buer J, Zell A, Autenrieth IB: Gene expression patterns of epithelial cells modulated by pathogenicity factors of Yersinia enterocolitica. Cell Microbiol 2004, 6(2):129-141.
  241. Wuestefeld T, Klein C, Streetz KL, Betz U, Lauber J, Buer J, Manns MP, Muller W, Trautwein C: Interleukin-6/glycoprotein 130-dependent pathways are protective during liver regeneration. J Biol Chem 2003, 278(13):11281-11288.
  242. Walter U, Toepfer T, Dittmar KE, Kretschmer K, Lauber J, Weiss S, Servos G, Lechner O, Scherbaum WA, Bornstein SR, Von Boehmer H, Buer J: Pancreatic NOD beta cells express MHC class II protein and the frequency of I-A(g7) mRNA-expressing beta cells strongly increases during progression to autoimmune diabetes. Diabetologia 2003, 46(8):1106-1114.
  243. Schrader AJ, Lauber J, Lechner O, Heidenreich A, Hofmann R, Buer J: Application of real-time reverse transcriptase-polymerase chain reaction in urological oncology. J Urol 2003, 169(5):1858-1864.
  244. Satyanarayana A, Wiemann SU, Buer J, Lauber J, Dittmar KE, Wustefeld T, Blasco MA, Manns MP, Rudolph KL: Telomere shortening impairs organ regeneration by inhibiting cell cycle re-entry of a subpopulation of cells. EMBO J 2003, 22(15):4003-4013.
  245. Samson SI, Richard O, Tavian M, Ranson T, Vosshenrich CA, Colucci F, Buer J, Grosveld F, Godin I, Di Santo JP: GATA-3 promotes maturation, IFN-gamma production, and liver-specific homing of NK cells. Immunity 2003, 19(5):701-711.
  246. Pulz M, Matussek A, Monazahian M, Tittel A, Nikolic E, Hartmann M, Bellin T, Buer J, Gunzer F: Comparison of a shiga toxin enzyme-linked immunosorbent assay and two types of PCR for detection of shiga toxin-producing Escherichia coli in human stool specimens. J Clin Microbiol 2003, 41(10):4671-4675.
  247. Matussek A, Lauber J, Bergau A, Hansen W, Rohde M, Dittmar KE, Gunzer M, Mengel M, Gatzlaff P, Hartmann M, Buer J, Gunzer F: Molecular and functional analysis of Shiga toxin-induced response patterns in human vascular endothelial cells. Blood 2003, 102(4):1323-1332.
  248. Franzke A, Piao W, Lauber J, Gatzlaff P, Konecke C, Hansen W, Schmitt-Thomsen A, Hertenstein B, Buer J, Ganser A: G-CSF as immune regulator in T cells expressing the G-CSF receptor: implications for transplantation and autoimmune diseases. Blood 2003, 102(2):734-739. 
  249. Buer J, Balling R: Mice, microbes and models of infection. Nat Rev Genet 2003, 4(3):195-205.
  250. Sechi AS, Buer J, Wehland J, Probst-Kepper M: Changes in actin dynamics at the T-cell/APC interface: implications for T-cell anergy? Immunol Rev 2002, 189:98-110.
  251. Schrader AJ, Lechner O, Templin M, Dittmar KE, Machtens S, Mengel M, Probst-Kepper M, Franzke A, Wollensak T, Gatzlaff P, Atzpodien J, Buer J, Lauber J: CXCR4/CXCL12 expression and signalling in kidney cancer. Br J Cancer 2002, 86(8):1250-1256.
  252. Salunkhe P, von Götz F, Wiehlmann L, Lauber J, Buer J, Tümmler B: GeneChip expression analysis of the response of Pseudomonas aeruginosa to Paraquat-induced superoxide stress. Genome Letters 2002, 4:165-174.
  253. Lechner O, Bruder D, Lauber J, Buer J: Anerge T-Zellen: Immunregulatoren für die Klinik. Die gelben Hefte 2002, 42:17-26.
  254. Garritsen HSP, Macke L, Lauber J, Buer J, Pagelow U, Rohde M, Hannig H, Pies A, Wormann B, Lindenmaier W, Dittmar KEJ: Genetically modified dendritic cells expressing two melanoma specific antigens simultaneously. Transfusion 2002, 42(9):50s-50s.
  255. Ehlers S, Lehmann J, Muller K, Laskay T, Buer J, Lauber J: Measuring immune responses in vivo. Method Microbiol 2002, 32:403-431.
  256. Lechner O, Lauber J, Franzke A, Sarukhan A, von Boehmer H, Buer J: Fingerprints of anergic T cells. Curr Biol 2001, 11(8):587-595.
  257. Hess S, Rheinheimer C, Tidow F, Bartling G, Kaps C, Lauber J, Buer J, Klos A: The reprogrammed host: Chlamydia trachomatis-induced up-regulation of glycoprotein 130 cytokines, transcription factors, and antiapoptotic genes. Arthritis Rheum 2001, 44(10):2392-2401.
  258. Franzke A, Buer J, Probst-Kepper M, Lindig C, Framzle M, Schrader AJ, Ganser A, Atzpodien J: HLA phenotype and cytokine-induced tumor control in advanced renal cell cancer. Cancer Biother Radiopharm 2001, 16(5):401-409.
  259. Felske A, Pauling BV, von Canstein HF, Li Y, Lauber J, Buer J, Wagner-Dobler I: Detection of small sequence differences using competitive PCR: molecular monitoring of genetically improved, mercury-reducing bacteria. Biotechniques 2001, 30(1):142-148.
  260. Walter U, Franzke A, Sarukhan A, Zober C, von Boehmer H, Buer J, Lechner O: Monitoring gene expression of TNFR family members by beta-cells during development of autoimmune diabetes. Eur J Immunol 2000, 30(4):1224-1232.
  261. Schrader AJ, Probst-Kepper M, Grosse J, Kunter U, Schenk F, Franzke A, Atzpodien J, Buer J: Molecular and prognostic classification of advanced melanoma: a multi-marker microcontamination assay of peripheral blood stem cells. Melanoma Res 2000, 10(4):355-362.
  262. Schrader AJ, Probst-Kepper M, Grosse J, Kunter U, Franzke A, Sel S, Atzpodien E, Buer J: Tumour microdissemination and survival in metastatic melanoma. Anticancer Res 2000, 20(5B):3619-3624.
  263. Oevermann K, Buer J, Hoffmann R, Franzke A, Schrader A, Patzelt T, Kirchner H, Atzpodien J: Capecitabine in the treatment of metastatic renal cell carcinoma. Br J Cancer 2000, 83(5):583-587.
  264. Wittke F, Hoffmann R, Buer J, Dallmann I, Oevermann K, Sel S, Wandert T, Ganser A, Atzpodien J: Interleukin 10 (IL-10): an immunosuppressive factor and independent predictor in patients with metastatic renal cell carcinoma. Br J Cancer 1999, 79(7-8):1182-1184.
  265. von Boehmer H, Aifantis I, Feinberg J, Lechner O, Saint-Ruf C, Walter U, Buer J, Azogui O: Pleiotropic changes controlled by the pre-T-cell receptor. Curr Opin Immunol 1999, 11(2):135-142.
  266. Hoffmann R, Franzke A, Buer J, Sel S, Oevermann K, Duensing A, Probst M, Duensing S, Kirchner H, Ganser A, Atzpodien J: Prognostic impact of in vivo soluble cell adhesion molecules in metastatic renal cell carcinoma. Br J Cancer 1999, 79(11-12):1742-1745.
  267. Franzke A, Peest D, Probst-Kepper M, Buer J, Kirchner GI, Brabant G, Kirchner H, Ganser A, Atzpodien J: Autoimmunity resulting from cytokine treatment predicts long-term survival in patients with metastatic renal cell cancer. J Clin Oncol 1999, 17(2):529-533.
  268. Atzpodien J, Buer J, Sel S, Janssen J, Oevermann K: Chemoimmunotherapy in the systemic treatment of advanced renal carcinoma. Urologe A 1999, 38(5):474-478.
  269. von Boehmer H, Aifantis I, Azogui O, Feinberg J, Saint-Ruf C, Zober C, Garcia C, Buer J: Crucial function of the pre-T-cell receptor (TCR) in TCR beta selection, TCR beta allelic exclusion and alpha beta versus gamma delta lineage commitment. Immunol Rev 1998, 165:111-119.
  270. Sarukhan A, Lanoue A, Franzke A, Brousse N, Buer J, von Boehmer H: Changes in function of antigen-specific lymphocytes correlating with progression towards diabetes in a transgenic model. EMBO J 1998, 17(1):71-80.
  271. Kirchner GI, Franzke A, Buer J, Beil W, Probst-Kepper M, Wittke F, Overmann K, Lassmann S, Hoffmann R, Kirchner H, Ganser A, Atzpodien J: Pharmacokinetics of recombinant human interleukin-2 in advanced renal cell carcinoma patients following subcutaneous application. Br J Clin Pharmacol 1998, 46(1):5-10.
  272. Hoffmann R, Muller I, Neuber K, Lassmann S, Buer J, Probst M, Oevermann K, Franzke A, Kirchner H, Ganser A, Atzpodien J: Risk and outcome in metastatic malignant melanoma patients receiving DTIC, cisplatin, BCNU and tamoxifen followed by immunotherapy with interleukin 2 and interferon alpha2a. Br J Cancer 1998, 78(8):1076-1080.
  273. Franzke A, Probst-Kepper M, Buer J, Duensing S, Hoffmann R, Wittke F, Volkenandt M, Ganser A, Atzpodien J: Elevated pretreatment serum levels of soluble vascular cell adhesion molecule 1 and lactate dehydrogenase as predictors of survival in cutaneous metastatic malignant melanoma. Br J Cancer 1998, 78(1):40-45.
  274. Buer J, Lanoue A, Franzke A, Garcia C, von Boehmer H, Sarukhan A: Interleukin 10 secretion and impaired effector function of major histocompatibility complex class II-restricted T cells anergized in vivo. J Exp Med 1998, 187(2):177-183.
  275. Aifantis I, Azogui O, Feinberg J, Saint-Ruf C, Buer J, von Boehmer H: On the role of the pre-T cell receptor in alphabeta versus gammadelta T lineage commitment. Immunity 1998, 9(5):649-655.
  276. Probst-Kepper M, Schrader A, Buer J, Grosse J, Volkenandt M, Illiger HJ, Metzner B, Kadar J, Duensing S, Hertenstein B, Ganser A, Atzpodien J: Detection of melanoma cells in peripheral blood stem cell harvests of patients with progressive metastatic malignant melanoma. Br J Haematol 1997, 98(2):488-490.
  277. Buer J, Probst M, Franzke A, Duensing S, Haindl J, Volkenandt M, Wittke F, Hoffmann R, Ganser A, Atzpodien J: Elevated serum levels of S100 and survival in metastatic malignant melanoma. Br J Cancer 1997, 75(9):1373-1376.
  278. Buer J, Probst M, Duensing S, Koditz H, Franzke A, Dallmann I, Ganser A, Atzpodien J: Clinical and in vitro response to 13-cis-retinoic acid in interferon-alpha resistant renal cell carcinoma. Cancer Biother Radiopharm 1997, 12(3):143-147.
  279. Buer J, Aifantis I, DiSanto JP, Fehling HJ, von Boehmer H: Role of different T cell receptors in the development of pre-T cells. J Exp Med 1997, 185(9):1541-1547.
  280. Buer J, Aifantis I, DiSanto JP, Fehling HJ, von Boehmer H: T-cell development in the absence of the pre-T-cell receptor. Immunol Lett 1997, 57(1-3):5-8.
  281. Aifantis I, Buer J, von Boehmer H, Azogui O: Essential role of the pre-T cell receptor in allelic exclusion of the T cell receptor beta locus. Immunity 1997, 7(5):601-607.
  282. Kunter U, Buer J, Probst M, Duensing S, Dallmann I, Grosse J, Kirchner H, Schluepen EM, Volkenandt M, Ganser A, Atzpodien J: Peripheral blood tyrosinase messenger RNA detection and survival in malignant melanoma. J Natl Cancer Inst 1996, 88(9):590-594.
  283. Duensing S, van den Berg-de Ruiter E, Storkel S, Kirchner H, Hanninen EL, Buer J, Poliwoda H, Atzpodien J: Cytogenetic studies in renal cell carcinoma patients receiving low-dose recombinant interleukin-2-based immunotherapy. Tumour Biol 1996, 17(1):27-33.
  284. Duensing S, Brevis Nunez F, Meyer N, Anastassiou G, Nasarek A, Grosse J, Buer J, Probst M, Ganser A, Alzpodien J: Exposure to vinblastine modulates beta 1 integrin expression and in vitro binding to extracellular matrix molecules in a human renal carcinoma cell line. Invasion Metastasis 1996, 16(2):65-72.
  285. Deckert M, Franzke A, Buer J, Probst M, Duensing S, Lopez-Haenninen E, Kirchner H, Poliwoda H, Atzpodien J: Linomide and interleukin-2 in patients with advanced renal cell carcinoma. Cancer Biother Radiopharm 1996, 11(5):319-324.
  286. Probst M, Buer J, Atzpodien J: Genetic abnormalities during transition from Helicobacter-pylori-associated gastritis to low-grade MALToma. Lancet 1995, 345(8951):723-724.
  287. Meffert M, Schomburg A, Hanninen EL, Menzel T, Vocke S, Dallmann I, Grosse J, Duensing S, Buer J, Kirchner H, et al.: In vivo tumor necrosis factor-alpha as indicator of biologic and clinical response to low-dose SC recombinant interleukin 2. Anticancer Res 1995, 15(1):127-132.
  288. Buer J, Probst M, Ganser A, Atzpodien J: Response to 13-cis-retinoic acid plus interferon alfa-2a in two patients with therapy-refractory advanced renal cell carcinoma. J Clin Oncol 1995, 13(10):2679-2680.
  289. Buer J, Probst M, Atzpodien J: Molecular diagnosis of neoplasms. N Engl J Med 1995, 333(3):193-194.
  290. Buer J, Hilse R, Dallmann I, Grosse J, Kirchner H, Zorn U, Hanninen EL, Franzke A, Duensing S, Poliwoda H, et al.: Lymphocyte-conditioned medium in combination with interleukin-2 effectively induces antitumour autoimmunity by adoptive transfer of short activated killer (SHAK) cells. Cytokines Mol Ther 1995, 1(1):39-46.
  291. Atzpodien J, Kirchner H, Duensing S, Lopez Hanninen E, Franzke A, Buer J, Probst M, Anton P, Poliwoda H: Biochemotherapy of advanced metastatic renal-cell carcinoma: results of the combination of interleukin-2, alpha-interferon, 5-fluorouracil, vinblastine, and 13-cis-retinoic acid. World J Urol 1995, 13(3):174-177.
  292. Meffert M, Hanninen EL, Menzel T, Schomburg A, Duensing S, Dallmann I, Grosse J, Vocke S, Buer J, Deckert M, et al.: In vivo time and dose dependency of interleukin-6 secretion in response to low-dose subcutaneous recombinant interleukin-2. Cancer Biother 1994, 9(4):307-316.
  293. Koch OM, Volkenandt M, Goker E, Buer J, Probst M, Banerjee D, Danenberg PV, Bertino JR: Molecular detection and characterization of clonal cell populations in acute lymphocytic leukemia by analysis of conformational polymorphisms of cRNA molecules of rearranged T-cell-receptor-gamma and immunoglobulin heavy-chain genes. Leukemia 1994, 8(6):946-952.
  294. Koch OM, Probst M, Tiemann M, Jakob I, Volkenandt M, Wienecke R, Buer J, Atzpodien J, Lenz HJ, Danenberg PV, et al.: Detection of clonal T-cell populations in gastrointestinal lymphomas by analysis of cRNA conformational polymorphisms of rearranged T-cell-receptor-gamma genes. Br J Haematol 1994, 86(2):316-321.
  295. Duensing S, Dallmann I, Grosse J, Buer J, Lopez Hanninen E, Deckert M, Storkel S, Kirchner H, Poliwoda H, Atzpodien J: Immunocytochemical detection of P-glycoprotein: initial expression correlates with survival in renal cell carcinoma patients. Oncology 1994, 51(4):309-313.
  296. Buer J, Kirchner H, Schomburg A, Schuler A, Manns M, Lopez-Hanninen E, Duensing S, Poliwoda H, Atzpodien J: Cytokine-based biotherapy of gastrointestinal tumors. Clin Investig 1994, 72(7):526-534.
  297. Volkenandt M, Wienecke R, Koch OM, Buer J, Probst M, Atzpodien J, Horikoshi T, Danenberg K, Danenberg P, Bertino JR: Conformational polymorphisms of cRNA of T-cell-receptor genes as a clone-specific molecular marker for cutaneous lymphoma. J Invest Dermatol 1993, 101(4):514-516.